Kikuchi-Fujimoto Disease
We talk about a lot of common, not-to-miss diagnoses here at the Morsel Bakery, but we also talk about remaining vigilant for more subtle or uncommon diagnoses. We have spoken about causes to consider when working up a Fever of Unknown Origin including Myocarditis, Osteomyelitis, Acute Rheumatic Fever, and Lemierres syndrome. Today’s topic is a very uncommon diagnosis (estimated <5000 people in the U.S. with this disease, though likely under-diagnosed), but is worth talking about when considering alternatives to other life-altering diseases that cause lymph node enlargement – Leukemia, Kawasaki Disease, Missed Kawasaki Disease, Neonatal Leukemia, or even Cat Scratch Disease. One of our pediatrics residents, Dr. Andrew Robinson, admitted a child for prolonged fever of unknown origin with lymphadenopathy, and this diagnosis was on the short list after lymph node biopsy! So, let’s find out more about Kikuchi-Fujimoto Disease.
Kikuchi-Fujimoto Disease: Basics
- Non-malignant condition of lymph nodes
- Also known as Histiocytic Necrotizing Lymphadenitis [Perry 2018, Selvanathan 2020, Fusconi 2023, Boone 2023]
- First described in 1972 by Kikuchi and Fujimoto independently [Perry 2018, Boone 2023]
- Seen worldwide, but higher prevalence in Japanese and other Asian populations [Perry 2018, Fusconi 2023]
- Found in both sexes, reports vary as to female vs male predominance [Fusconi 2023]
- Usually in children and young adults, but can be any age [Fusconi 2023]
- Unclear etiology but infectious and autoimmune causes are sometimes suggested [Perry 2018, Fusconi 2023, Boone 2023]
- Suspected that an infectious agent (viral, bacterial, otherwise) triggers an inflammatory response
- There may be a genetic predisposition to it as there are some HLA class 2 genes that are more frequent in patients who have the disease [Boone 2023]
Kikuchi-Fujimoto Disease: Presentation and Exam
- Can present with regional lymph node swelling (cervical, axillary, supraclavicular) [Perry 2018, Selvanathan 2020, Fusconi 2023, Boone 2023]
- Lymph nodes tend to be 2-3 cm in size but can be up to 6 cm
- Lymph nodes are firm and mobile but not fluctuant or draining
- Frequent symptoms are fever, night sweats, myalgia, leukopenia, anemia [Selvanathan 2020, Fusconi 2023, Boone 2023]
- Less commonly weight loss, nausea, vomiting, pharyngitis, rash, abdominal pain [Selvanathan 2020, Fusconi 2023, Boone 2023]
- Rarely hepatomegaly, splenomegaly [Fusconi 2023]
- Rare extra nodal sites of involvement- bone marrow, myocardium, uvea, thyroid and parotid glands [Boone 2023]
- Neurologic involvement is rare [Boone 2023]
- Aseptic meningitis
- Cerebellar ataxia
- Encephalitis
- Lab findings: leukopenia, elevated ESR, elevated liver enzymes [Boone 2023]
Kikuchi-Fujimoto Disease: Differential
- Other things to consider on the differential [Perry 2018, Boone 2023]
- Atypical mycobacterial lymphadenitis
- Cat Scratch Disease (Cat Scratch Fever)
- Epstein-Barr Virus (EBV) Infectious Mononucleosis (Mono)
- Herpes Simplex Lymphadenitis
- Kawasaki Disease
- Metastatic Carcinoma
- Myeloid Sarcoma
- Leprosy
- Leukemia
- Lymphoma
- Differentiate Kikuchi disease by presence of incomplete lymph node architectural effacement with patent sinuses
- Numerous reactive histiocytes
- Low mitotic rates
- Absence of Reed-Sternberg cells
- Rheumatoid Arthritis Lymphadenitis
- Sarcoidosis
- Still Disease
- Syphilis
- Systemic Lupus Erythematosus (SLE)
- Differentiate Kikuchi disease by relative absence of hematoxylin bodies, plasma cells, and neutrophils
- Toxoplasmosis
- Tuberculosis (TB)
- Tularemia
- Yersinia enterocolitica lymphadenitis
Kikuchi-Fujimoto Disease: Diagnosis
- By lymph node biopsy– histological analysis and immunohistochemistry [Perry 2018, Fusconi 2023, Boone 2023]
- Paracortical necrosis
- Histiocytes
- Lymphocytes
- Plasmacytoid monocytes
- Macrophages
- T cell immunoblasts
- Karyorrhexis
- Absent or rare- neutrophils, granulomas, plasma cells
- 3 phases of disease [Perry 2018, Boone 2023]
- Proliferative phase– typical findings as noted above
- Necrotizing phase– necrosis destroys architecture of lymph node
- Xanthomatous phase (“foamy cell”)- recovery, resolving necrosis
- CBC may show [Boone 2023]
- Mild granulocytopenia (20-50%)
- Leukocytosis (2-5%)
- Atypical lymphocytes (25%)
- May have Elevated ESR and CRP or elevated LDH [Boone 2023]
- Rheumatoid factor (RF), Antinuclear antibody (ANA) and other autoimmune antibody studies usually are negative
- Must rule out other critical diagnoses- lymphoma, metastasis or tuberculous adenitis
- Histology may reveal [Fusconi 2023]
- Follicular hyperplasia with paracortical infiltration of histiocytes and lymphocytes
- Absence of neutrophils and eosinophils (in the proliferative stage)
- Necrotic foci with a high degree of karyorrhexis (in the necrotizing stage)
- Imaging [Boone 2023]
- Some studies suggest that CT imaging can help differentiate Kikuchi disease from tuberculous lymphadenopathy with a different distribution of lymph node involvement
- Ultrasound can be used but is also not diagnostic
- Chest X Ray is not helpful for Kikuchi disease specifically, but should be obtained to evaluate for tuberculosis or malignancy
Kikuchi-Fujimoto Disease: Treatment
- Symptomatic treatment! Antipyretics, analgesics, NSAIDs [Fusconi 2023, Boone 2023]
- Corticosteroids used rarely but for severe cases [Fusconi 2023]
- For steroid-resistant cases or recurrence [Boone 2023]
- Hydroxychloroquine
- Intravenous immunoglobulin (IVIG)
- Monitor for several years to look for possible development of SLE
- Spontaneously resolves in 1-6 months [Perry 2018, Fusconi 2023, Boone 2023]
Kikuchi-Fujimoto Disease: Complications
- Sometimes associated with systemic lupus erythematosus [Fusconi 2023, Boone 2023]
- May have co-occurrence with other autoimmune diseases- relapsing polychondritis, Sjögren-Larsson syndrome, systemic sclerosis or antiphospholipid syndrome [Fusconi 2023]
- May suggest that the immune systems of patients are altered
- Development of hemophagocytic lymphohistiocytosis HLH reported [Selvanathan 2020]
- May have recurrence 3-4% or up to 12.2% of the time [Selvanathan 2020, Fusconi 2023]
- Fatal cases have been reported, but are very rare [Fusconi 2023]
- If misdiagnosed with lymphoma first, may receive unnecessary treatment with chemotherapy [Dorfman 1988]
- Many receive antibiotics at first presentation, which may come with their own complications [Selvanathan 2020]
Moral of the Morsel
- Stay Vigilant! There are other things besides malignancy that can cause fever, lymphadenopathy, and weight loss.
- Be Supportive! Supportive care for Kikuchi Disease is the main treatment, but even before you know this diagnosis, do what you can to make your patient comfortable.
- Misery Loves Company! Be cognizant that SLE is closely associated with Kikuchi Disease and may present concurrently or years later.
Where to Find Out More:
GARD- The Genetic and Rare Diseases Information Center
NORD- National Organization for Rare Diseases
References:
- Anamarija M. Perry, Sarah M. Choi; Kikuchi-Fujimoto Disease: A Review. Arch Pathol Lab Med 1 November 2018; 142 (11): 1341–1346. doi: https://doi.org/10.5858/arpa.2018-0219-RA
- Selvanathan SN, Suhumaran S, Sahu VK, Chong CY, Tan NWH, Thoon KC. Kikuchi-Fujimoto disease in children. J Paediatr Child Health. 2020 Mar;56(3):389-393. doi: 10.1111/jpc.14628. Epub 2019 Oct 1. PMID: 31576642.
- Fusconi, M. and Zaccharelli, F. (2023) Knowledge on rare diseases and orphan drugs, Orphanet: Kikuchi-Fujimoto disease. Available at: https://www.orpha.net/en/disease/detail/50918 (Accessed: 02 September 2024).
- John Boone, M. and Charles, K.S. (2023) Kikuchi disease. Available at: https://emedicine.medscape.com/article/210752-overview?form=fpf (Accessed: 03 September 2024).
- Dorfman RF, Berry GJ. Kikuchi’s histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis. Semin Diagn Pathol. 1988 Nov;5(4):329-45. PMID: 3217625.
- Kikuchi-Fujimoto Disease Genetic and Rare Diseases Information Center. Available at: https://rarediseases.info.nih.gov/diseases/6834/kikuchi-fujimoto-disease (Accessed: 02 September 2024).